LAUSR

Remdesivir: Quo vadis?

Sign Up to like & get
recommendations!
0 Published in 2021 at "Biochemical Pharmacology"

DOI: 10.1016/j.bcp.2021.114800

Abstract: Remdesivir (GS-5734, Veklury®) has remained the only antiviral drug formally approved by the US FDA for the treatment of Covid-19 (SARS-CoV-2 infection). Its key structural features are the fact that it is a C-nucleoside (adenosine)… read more here.

Keywords: remdesivir; pharmacology; remdesivir quo; quo vadis ... See more keywords